Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Queensland Health
Argus Health
US Department of Justice
Harvard Business School
AstraZeneca

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 6,338,844

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,338,844
Title: Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use
Abstract:A nucleic acid with which expression of a polypeptide having interleukin-16 activity can be achieved or regulated in a prokaryotic or eukaryotic host cell, wherein in the region coding for the polypeptide, the nucleic acid (1) corresponds to the DNA sequence SEQ ID NOS:1 and 5-7 or its complementary strand; (b) hybridizes under stringent conditions with the DNA of sequence SEQ ID NOS:1 and 5-7; (c) or is a nucleic acid sequence which, if there was no degeneracy of the genetic code, would hybridize under stringent conditions with the nucleic acid sequences defined by (a) and (b); (d) and, if it codes for a polypeptide having interleukin-16 activity, is suitable as genomic DNA for the recombinant production of IL-16 in eukaryotic host cells and processes for producing the same and pharmaceutical compositions containing the same.
Inventor(s): Kurth; Reinhard (Dreieich, DE), Baier; Michael (Frankfurt, DE), Bannert; Norbert (Frankfurt, DE), Metzner; Karin (Frankfurt, DE), Werner; Albrecht (Weinheim, DE)
Assignee: Bundesrepublik Deutschland vertreten durch de Bundesminister fur Gesundheit (Bonn, DE)
Application Number:09/147,119
Patent Claims:see list of patent claims

Details for Patent 6,338,844

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Bundesrepublik Deutschland vertreten durch de Bundesminister fur Gesundheit (Bonn, DE) 2016-04-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Bundesrepublik Deutschland vertreten durch de Bundesminister fur Gesundheit (Bonn, DE) 2016-04-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Bundesrepublik Deutschland vertreten durch de Bundesminister fur Gesundheit (Bonn, DE) 2016-04-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Queensland Health
Johnson and Johnson
Chubb
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.